Comparison of Daily Home Hemodialysis (HD) With Conventional in Center HD in Terms of Patients Quality of Life and Clinical Outcomes
NCT ID: NCT03737578
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
160 participants
INTERVENTIONAL
2018-06-27
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Physical Activity for Hemodialysis Patients
NCT02860312
Contribution of Per Dialytic Physical Activity in Chronic Dialysis Patients
NCT06471283
The Effect of Home Based Tele-Exercise on Peritoneal Dialysis Patients
NCT06787599
Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
NCT07269379
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
NCT00667511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective of this study is to evaluate the physical activity in the daily life of patients in daily hemodialysis in comparison with patients treated 3 times a week (conventional hemodialysis) others objectives are also:
1. To describe the characteristics of daily hemodialysis patients;
2. To describe the prescription procedures of the home daily HD;
3. To compare the evolution of the blood pressure between the 2 modalities of hemodialysis;
4. To compare the frequency of hospitalizations, duration and hospitalization reasons between the 2 hemodialysis modalities;
5. To compare the quality of life of the patients between the 2 modalities ;
6. To evaluate the quality of the sleep of the patients between the 2 modalities ;
7. Compare the percentage of patients with restless leg syndrome (RLS) and the severity of RLS between the two modalities;
8. Compare the evolution of drug intake between the two modalities;
9. Evaluate the number of abandoning subjects and causes of discontinuation of HQD;
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Daily hemodialysis patients
Description: End stage renal disease patients starting daily hemodialysis treatment.
Interventions: Delivery of a connected pedometer / accelerometer and Quality Of Life and Restless Leg Syndrome questionnaires.
Delivery of a connected pedometer / accelerometer
Delivery of a connected pedometer / accelerometer that the patient will be asked to wear at least 7 consecutive days / month.
Quality of life and leg restless syndrome questionnaires (auto questionnaire) completed by the patients every 3 months
Conventional hemodialysis patients
Description: End stage renal disease patients currently treated by conventional hemodialysis or starting conventional hemodialysis treatment.
Interventions: Delivery of a connected pedometer / accelerometer and Quality Of Life and Restless Leg Syndrome questionnaires.
Delivery of a connected pedometer / accelerometer
Delivery of a connected pedometer / accelerometer that the patient will be asked to wear at least 7 consecutive days / month.
Quality of life and leg restless syndrome questionnaires (auto questionnaire) completed by the patients every 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delivery of a connected pedometer / accelerometer
Delivery of a connected pedometer / accelerometer that the patient will be asked to wear at least 7 consecutive days / month.
Quality of life and leg restless syndrome questionnaires (auto questionnaire) completed by the patients every 3 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient who dated and signed the consent form
3. Patient (s) affiliated to a Social Security scheme
4. Interventional arm: patient who begins or will begin daily hemodialysis training (5, 6 or 7 times per week) at home.
5. Comparator arm: prevalent or incident patient treated by conventional hemodialysis (3 times per week) and fitting with the matching criteria of an interventional patient included in the center
Exclusion Criteria
2. Patient with active neoplasia;
3. Patient with predicted life expectancy of less than one year;
4. Patient with significant reading or writing difficulties;
5. Patient participating in a clinical trial or other interventional study; 6. Patient with history of mental instability, major cognitive impairment in the previous 5 years, or major psychiatric condition not adequately controlled or stable under pharmacological treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Physidia
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalia Target, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier La Roche sur Yon - France
Cécile Courivaud, MD
Role: STUDY_CHAIR
CHRU Jean Minjoz, Besançon, France
Pierre Antoine Michel, MD
Role: STUDY_CHAIR
Hôpital Tenon APHP, Paris, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier
La Roche-sur-Yon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Target N, Courivaud C, Michel PA, Daoud S, Thomas M. Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol. BMC Nephrol. 2020 Nov 23;21(1):500. doi: 10.1186/s12882-020-02127-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018A00838-47
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.